Cargando…

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker

BACKGROUND: Centromere protein L (CENPL) is an important member of the centromere protein (CENP) family. However, the correlation between CENPL expression and cancer development and immune infiltration has rarely been studied. Here, we studied the role of CENPL in pan-cancer and further verified the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Ziyang, Chen, Yu, Cai, Changjing, Tan, Jun, Liu, Ping, Chen, Yihong, Shen, Hong, Zeng, Shan, Han, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279617/ https://www.ncbi.nlm.nih.gov/pubmed/35844598 http://dx.doi.org/10.3389/fimmu.2022.916594

Ejemplares similares

Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltration
por: Gui, Zhengwei, et al.
Publicado: (2023)

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer
por: Gao, Yan, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
por: Chen, Rui, et al.
Publicado: (2022)

Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
por: Huang, Tingting, et al.
Publicado: (2022)

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma
por: Feng, Ziyang, et al.
Publicado: (2022)

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers
por: Chen, Yihong, et al.
Publicado: (2023)

High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients
por: Cui, Zhongyuan, et al.
Publicado: (2021)

Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors
por: Qiao, Han, et al.
Publicado: (2022)

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma
por: He, Min, et al.
Publicado: (2021)

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients
por: Shen, Edward, et al.
Publicado: (2021)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
por: Zhong, Chenming, et al.
Publicado: (2022)

Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients
por: Cui, Zhongyuan, et al.
Publicado: (2022)

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model
por: Cai, Changjing, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma
por: Zhu, Zheng-yi, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response
por: Song, Jing, et al.
Publicado: (2021)

Correction: Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients
por: Cui, Zhongyuan, et al.
Publicado: (2023)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer
por: Zhong, Hongguang, et al.
Publicado: (2023)

Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker
por: Fang, Tao, et al.
Publicado: (2022)

RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer
por: Qin, Yiming, et al.
Publicado: (2023)

M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer
por: Cai, Changjing, et al.
Publicado: (2021)

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis
por: Zhao, Guang, et al.
Publicado: (2022)

Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis
por: Li, Xin-yu, et al.
Publicado: (2022)

Identification of biomarkers associated with CD8+ T cells in rheumatoid arthritis and their pan-cancer analysis
por: Zhao, Zhenyu, et al.
Publicado: (2022)

A Pan-Cancer Analysis of Tumor-Infiltrating B Cell Repertoires
por: Yu, Katharine, et al.
Publicado: (2022)

Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer
por: Zou, Ruoyao, et al.
Publicado: (2022)

Immune-infiltrating signature-based classification reveals CD103(+)CD39(+) T cells associate with colorectal cancer prognosis and response to immunotherapy
por: Luo, Yang, et al.
Publicado: (2022)

Insights into prognosis and immune infiltration of cuproptosis-related genes in breast cancer
por: Huang, Tingting, et al.
Publicado: (2022)

Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
por: Khan, Muhammad, et al.
Publicado: (2022)

FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer
por: Zhong, Anyuan, et al.
Publicado: (2021)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer
por: Jin, Liang, et al.
Publicado: (2022)

Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
por: Li, Zhanzhan, et al.
Publicado: (2023)

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
por: Liu, Chengdong, et al.
Publicado: (2021)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
por: Li, Xinyu, et al.
Publicado: (2020)

Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy
por: Yao, Shijie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_53ioft3p8odg1t71qvlmki7q75